« Previous
Next »
Seminars in Thoracic and Cardiovascular Surgery
Volume 20, Issue 2
, Pages 115-118
, Summer 2008
MSC Immune Tolerance in Cellular Cardiomyoplasty
References
- Human mesenchymal stem cells differentiae to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105:93–98
- Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature Med. 2000;6:1282–1286
- Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg. 2002;74:19–24
- Persistence of marrow stromal cells implanted into acutely infracted myocardium: observations in a xenotransplant model. J Thorac Cardiovasc Surg. 2005;130:1114–1121
- Marrow stromal cells as “universal donor cells” for myocardial regenerative therapy: their unique immune tolerance. Ann Thorac Surg. 2008;85:571–580
- Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation. 2005;112:214–223
- Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. PNAS. 2005;102:11474–11479
- The impact of intravenous allogeneic human mesenchymal stem cells (Provacel™) on ejection fraction in patients with myocardial infarction. Circulation. 2007;116:II-202
- . Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110:3499–3506
- . Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815–1822
- Marrow stromal cells for cellular cardiomyoplasty: feasibility and clinical advantages. J Thorac Cardiovasc Surg. 2000;120:999–1006
- HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exper Hematol. 2003;31:890–896
- The immunobiological development of human bone marrow mesenchymal stem cells in the course of neuronal differentiation. Cellular Immunol. 2006;244:19–32
- . “Stealth immune tolerance” in stem cell transplantation: potential for “universal donors” in myocardial regenerative therapy. J Heart Lung Transplant. 2005;24:511–516
- . The danger model: a renewed sense of self. Science. 2002;296:301–305
- Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation. 2007;83:783–790
- Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infracted rat myocardium. J Thorac Cardiovasc Surg. 2004;127:1293–1300
- Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Ann Med. 2006;38:144–153
- They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-based lymphocyte host immune response. Eur J Cardiothorac Surg. 2005;28:461–466
- Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA. 1996;93:705–708
PII: S1043-0679(08)00055-5
doi: 10.1053/j.semtcvs.2008.03.004
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Thoracic and Cardiovascular Surgery
Volume 20, Issue 2
, Pages 115-118
, Summer 2008
